QLD MS Symposium 2017

  • Overview
  • Venue
Date(s): 02 November 2017 - 03 November 2017
Location: Brisbane
Language: English

Join Waters at the 2nd Queensland Mass Spectrometry Symposium.

Thursday, 2 - Friday, 3 November 2017

QIMR Berghofer Medical Research Institute

300 Herston Road

Herston, QLD 4006

The second Queensland Mass Spectrometry Symposium will highlight the cutting edge research & Applications of mass spectrometry in Queensland. The two day program will incorporate poster and networking sessions as well as workshops.

QIMR Berghofer is the world leading medical research institute, renowned for its efforts in both discovery research and translational research.  The Institute's research is focussed on cancer, infectious diseases, mental health and chronic disorders. Working in close collaboration with clinicians and research institutes in Australia and around the world, the institute's aim is to improve the future of health by developing prevention strategies, new diagnostics and better treatments.

All  researchers and users of mass spectrometry technology are invited to participate at the symposium.

Symposium topics include:

  • Proteomics, post-translational modifications
  • Metabolomics, lipidomics
  • Systems biology
  • Clinical applications
  • Veterinary and agricultural applications
  • Toxicology and environmental applications

Waters Australia is a proud sponsor of the 2nd Queensland Mass Spectrometry Symposium, please join us at our trade display.


Don't miss the Waters workshops at QLD Mass Spectrometry Symposium.

Friday, 3rd November 2:00 - 2:45pm

Novel technologies to improve your workflows and discoveries 

Over the past 60 years, Waters have pioneered a connected portfolio of separations and analytical science, laboratory informatics and mass spectrometry. Todays workshop will be discussing two of our novel technologies and how they allow scientists to improve their workflows and discoveries.

1. Introducing the Waters QDa Mass Detector into a high-throughput clinical service  

B C McWhinney 

Pathology Queensland, Herston Hospitals Complex, Brisbane, Queensland 4029, Australia 


The increasing demands of improving turn-around-time, reducing assay costs and the flexibility to introduce new testing regimes has driven many pathology providers to assess their current technology platforms. The introduction of the Waters QDa mass detector has allowed laboratories to transfer complex HPLC assays with long run times into simple, robust, fast UPLC assays that require minimal sample preparation. Three practical examples will be presented that demonstrates the utility, specificity and cost saving capabilities of this detector platform. 


The implementation of the QDa mass detector into our high-throughput clinical service has improved laboratory efficiency, significantly reduced the time to result generation and achieved significant gains in quality. Consequently, patient management has improved. 

2. Proteomics Applications Using SONAR, a New Mass Spectrometry Data Independent Acquisition Mode 

Christopher Buck 

Waters Australia 

The data independent acquisition (DIA) mode for mass spectrometry SONAR is ideally suited for untargeted discovery techniques. It is an unbiased method in its data collection, providing a scan rate which allows for reliable quantitation of all components in a sample, while also reducing spectral complexity for greater confidence in peptide or metabolite identifications. As a very fast DIA method it is compatible with high speed chromatographic and electrophoretic separations enabling high sample throughput and high sensitivity.